Table 1. Patient characteristics of men who completed the IPSS and/or the SHIM/IIEF-5.
| Characteristics | IPSS, N=845 | SHIM/IIEF-5, N=696 |
|---|---|---|
| Age at diagnosis (years) | ||
| Median [IQR] | 64 [59–69] | 64 [59–68] |
| Unknown (n) | 74 | 75 |
| PSA at inclusion (ng/mL) | ||
| Median [IQR] | 5.1 [3.7–6.8] | 5.1 [3.5–6.7] |
| Unknown (n) | 8 | 7 |
| Grade group at inclusion | ||
| GG1 | 787 (93%) | 652 (94%) |
| GG2 | 50 (6%) | 39 (6%) |
| GG3 | 8 (1%) | 5 (1%) |
| Max % cancer in any core | ||
| Median [IQR] | 10 [5–25] | 10 [5–25] |
| Unknown (n) | 57 | 39 |
| cT stage | ||
| T1c | 692 (82%) | 576 (83%) |
| T2a | 85 (10%) | 65 (9%) |
| T2-unspecified | 32 (4%) | 23 (3%) |
| T2b | 9 (1%) | 8 (1%) |
| T2c | 13 (2%) | 10 (1%) |
| Unknown | 14 (2%) | 14 (2%) |
| Number of biopsies, median [IQR] | 3 [2–4] | 3 [2–5] |
| Number of biopsy cores per session, median [IQR] | 12 [12–17] | 12 [12–17] |
| Time on AS in months, median [IQR] | 35 [19–56] | 36 [20–55] |
IPSS, International Prostate Symptom Score; SHIM, Sexual Health Inventory for Men; IIEF-5, five item International Index of Erectile Function; AS, active surveillance; IQR, interquartile range.